Status:
COMPLETED
Measurement of Recirculation During Venovenous Extracorporeal Membrane Oxygenation (VV ECMO)
Lead Sponsor:
Transonic Systems Inc.
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Venovenous Extracorporeal Membrane Oxygenation
Recirculation
Eligibility:
All Genders
Up to 21 years
Brief Summary
This study is to test the usefulness of ultrasound dilution recirculation measurements in patients receiving venovenous extracorporeal membrane oxygenation as therapy. The ultrasound dilution measurem...
Detailed Description
At the present time there are no devices available to measure recirculation in patients on venovenous extracorporeal membrane oxygenation. The study uses an external monitor, laptop computer, clamp on...
Eligibility Criteria
Inclusion
- Patients between 0 and 21 years of age
- Patients receiving venovenous extracorporeal membrane oxygenation as treatment.
Exclusion
- Patients over 21 years of age
- Patients not receiving venovenous extracorporeal membrane oxygenation.
Key Trial Info
Start Date :
June 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00920062
Start Date
June 1 2007
End Date
June 1 2013
Last Update
May 27 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Crouse Hospital
Syracuse, New York, United States, 13210